logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Stage I/II HCC: resection yields survival benefit over ablation.

NCDB analysis shows benefit regardless of tumor size or degree of underlying fibrosis.